Literature DB >> 15967158

Cytokines, PGE2 and endotoxic fever: a re-assessment.

Clark M Blatteis1, Shuxin Li, Zhonghua Li, Carlos Feleder, Vit Perlik.   

Abstract

The innate immune system serves as the first line of host defense against the deleterious effects of invading infectious pathogens. Fever is the hallmark among the defense mechanisms evoked by the entry into the body of such pathogens. The conventional view of the steps that lead to fever production is that they begin with the biosynthesis of pyrogenic cytokines by mononuclear phagocytes stimulated by the pathogens, their release into the circulation and transport to the thermoregulatory center in the preoptic area (POA) of the anterior hypothalamus, and their induction there of cyclooxygenase (COX)-2-dependent prostaglandin (PG)E(2), the putative final mediator of the febrile response. But data accumulated over the past 5 years have gradually challenged this classical concept, due mostly to the temporal incompatibility of the newer findings with this concatenation of events. Thus, the former studies generally overlooked that the production of cytokines and the transduction of their pyrogenic signals into fever-mediating PGE(2) proceed at relatively slow rates, significantly slower certainly than the onset latency of fever produced by the i.v. injection of bacterial endotoxic lipopolysaccharides (LPS). Here, we review the conflicts between the earlier and the more recent findings and summarize new data that reconcile many of the contradictions. A unified model based on these data explicating the generation and maintenance of the febrile response is presented. It postulates that the steps in the production of LPS fever occur in the following sequence: the immediate activation by LPS of the complement (C) cascade, the stimulation by the anaphylatoxic C component C5a of Kupffer cells, their consequent, virtually instantaneous release of PGE(2), its excitation of hepatic vagal afferents, their transmission of the induced signals to the POA via the ventral noradrenergic bundle, and the activation by the thus, locally released norepinephrine (NE) of neural alpha(1)- and glial alpha(2)-adrenoceptors. The activation of the first causes an immediate, PGE(2)-independent rise in core temperature (T(c)) [the early phase of fever; an antioxidant-sensitive PGE(2) rise, however, accompanies this first phase], and of the second a delayed, PGE(2)-dependent T(c) rise [the late phase of fever]. Meanwhile-generated pyrogenic cytokines and their consequent upregulation of blood-brain barrier cells COX-2 also contribute to the latter rise. The consecutive steps that initiate the febrile response to LPS would now appear, therefore, to occur in an order different than conceived originally.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15967158     DOI: 10.1016/j.prostaglandins.2005.01.001

Source DB:  PubMed          Journal:  Prostaglandins Other Lipid Mediat        ISSN: 1098-8823            Impact factor:   3.072


  42 in total

1.  Anti-inflammatory effects of benfotiamine are mediated through the regulation of the arachidonic acid pathway in macrophages.

Authors:  Mohammad Shoeb; Kota V Ramana
Journal:  Free Radic Biol Med       Date:  2011-10-24       Impact factor: 7.376

Review 2.  Acetaminophen and diphenhydramine premedication for allergic and febrile nonhemolytic transfusion reactions: good prophylaxis or bad practice?

Authors:  Terrence L Geiger; Scott C Howard
Journal:  Transfus Med Rev       Date:  2007-01

Review 3.  Fever and the thermal regulation of immunity: the immune system feels the heat.

Authors:  Sharon S Evans; Elizabeth A Repasky; Daniel T Fisher
Journal:  Nat Rev Immunol       Date:  2015-05-15       Impact factor: 53.106

Review 4.  Obesity-associated cancer risk: the role of intestinal microbiota in the etiology of the host proinflammatory state.

Authors:  Zora Djuric
Journal:  Transl Res       Date:  2016-07-28       Impact factor: 7.012

Review 5.  Fever.

Authors:  Tamas Bartfai; Bruno Conti
Journal:  ScientificWorldJournal       Date:  2010-03-16

6.  A randomized controlled trial of chloroquine for the treatment of dengue in Vietnamese adults.

Authors:  Vianney Tricou; Nguyet Nguyen Minh; Toi Pham Van; Sue J Lee; Jeremy Farrar; Bridget Wills; Hien Tinh Tran; Cameron P Simmons
Journal:  PLoS Negl Trop Dis       Date:  2010-08-10

7.  PKA, Rap1, ERK1/2, and p90RSK mediate PGE2 and EP4 signaling in neonatal ventricular myocytes.

Authors:  Quan He; Pamela Harding; Margot C LaPointe
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-10-30       Impact factor: 4.733

8.  Central control of fever and female body temperature by RANKL/RANK.

Authors:  Reiko Hanada; Andreas Leibbrandt; Toshikatsu Hanada; Shiho Kitaoka; Tomoyuki Furuyashiki; Hiroaki Fujihara; Jean Trichereau; Magdalena Paolino; Fatimunnisa Qadri; Ralph Plehm; Steffen Klaere; Vukoslav Komnenovic; Hiromitsu Mimata; Hironobu Yoshimatsu; Naoyuki Takahashi; Arndt von Haeseler; Michael Bader; Sara Sebnem Kilic; Yoichi Ueta; Christian Pifl; Shuh Narumiya; Josef M Penninger
Journal:  Nature       Date:  2009-11-26       Impact factor: 49.962

9.  Dengue and relative bradycardia.

Authors:  Aisha Lateef; Dale Andrew Fisher; Paul Ananth Tambyah
Journal:  Emerg Infect Dis       Date:  2007-04       Impact factor: 6.883

10.  Neonatal lipopolysaccharide exposure delays puberty and alters hypothalamic Kiss1 and Kiss1r mRNA expression in the female rat.

Authors:  A M I Knox; X F Li; J S Kinsey-Jones; E S Wilkinson; X Q Wu; Y S Cheng; S R Milligan; S L Lightman; K T O'Byrne
Journal:  J Neuroendocrinol       Date:  2009-06-04       Impact factor: 3.627

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.